Variable | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P | |
Age | ||||
 <60 | 1 |  | 1 |  |
 ≥60 | 1.63 (1.44–1.86) | <0.001 | 1.87 (1.64–2.14) | <0.001 |
Sex | ||||
 Male | 1 |  |  |  |
 Female | 1.09 (0.97–1.21) | 0.134 |  |  |
Race | ||||
 Black | 1 |  |  |  |
 White | 1.01 (0.85–1.21) | 0.881 |  |  |
 Others (AI, API) | 0.91 (0.71–1.18) | 0.482 |  |  |
Martial status | ||||
 Unmarried | 1 |  | 1 |  |
 Married | 0.76 (0.68–0.85) | <0.001 | 0.84 (0.75–0.93) | 0.0014 |
Primary site | ||||
 Left colona | 1 |  | 1 |  |
 Right colonb | 1.01 (0.88–1.15) | 0.907 |  |  |
 Overlapping lesion of colon | 1.33 (0.9–1.97) | 0.145 |  |  |
 Rectumc | 1.1 (0.86–1.41) | 0.429 |  |  |
Tumor size (mm) | ||||
 ≤50 | 1 |  | 1 |  |
 >50 | 1.17 (1.05–1.31) | 0.005 | 1.04 (0.92–1.17) | 0.5454 |
Grade | ||||
 Grade I/II | 1 |  | 1 |  |
 Grade III/IV | 1.8 (1.6–2.03) | <0.001 | 1.26 (1.12–1.43) | <0.001 |
pT stage | ||||
 pT1 | 1 |  | 1 |  |
 pT2 | 1.42 (0.87–2.34) | 0.161 | 1.26 (0.77–2.07) | 0.361 |
 pT3 | 1.98 (1.26–3.13) | 0.003 | 1.31 (0.82–2.08) | 0.2591 |
 pT4 | 4.54 (2.87–7.17) | <0.001 | 1.93 (1.2–3.1) | 0.0068 |
pN stage | ||||
 pN0 | 1 |  | 1 |  |
 pN1 | 1.74 (1.52-2) | <0.001 | 1.5 (1.28–1.76) | <0.001 |
 pN2 | 3.58 (3.14–4.07) | <0.001 | 2.42 (2.05–2.85) | <0.001 |
M stage | ||||
 M0 | 1 |  | 1 |  |
 M1 | 5.35 (4.75–6.02) | <0.001 | 3.2 (2.76–3.7) | <0.001 |
CEA | ||||
 Negative | 1 |  | 1 |  |
 Positive | 2 (1.79–2.23) | <0.001 | 1.4 (1.24–1.57) | <0.001 |
PNI | Â | Â | Â | |
 Negative | 1 |  |  |  |
 Positive | 2.4 (2.08–2.76) | <0.001 | 1.21 (1.04–1.41) | 0.0146 |
TD | ||||
 Negative | 1 |  |  |  |
 Positive | 3.23 (2.86–3.65) | <0.001 | 1.52 (1.31–1.75) | <0.001 |
RNE | ||||
 <12 | 1 |  |  |  |
 ≥12 | 0.52 (0.44–0.61) | <0.001 | 0.65 (0.55–0.78) | <0.001 |
Chemotherapy | ||||
 No/Unknown | 1 |  | 1 |  |
 Yes | 1.29 (1.15–1.43) | <0.001 | 0.61 (0.54–0.7) | <0.001 |